Thermalin offers insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.
Industries BiotechnologyHealth CareLife ScienceMedicalHeadquarters Regions Great Lakes, Midwestern US Founded Date 2010 Founders Michael Weiss, Richard Berenson Operating Status Active Last Funding Type Venture - Series Unknown Also Known As Thermalin Diabetes Legal Name Thermalin Inc.
Company Type For Profit
Contact Email rick@thermalin.com Phone Number 617-695-0523
Thermalin hopes to disrupt the $30B insulin/insulin delivery market with a disposable, postage-stamp-sized glucose management system enabled by our first-in-class stabilized, highly concentrated, and ultra-rapid acting insulin. This same new insulin molecule in "ordinary" (U-100) concentration will enable the factory-filling of
reservoirs for existing insulin pumps. In addition to this lead program, Thermalin is developing partnerships on no-cold-chain basal and mix insulins and on glucose-responsive insulins.